Related Experiment Video
Updated: May 30, 2026
Compact Quantum Dots for Single-molecule Imaging
Published on: October 9, 2012
Single-domain antibody bioconjugated near-IR quantum dots for targeted cellular imaging of pancreatic cancer
Md Badruz Zaman1, Toya Nath Baral, Zygmunt J Jakubek
1Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario K1A 0R6, Canada.
Abstract:
Successful targeted imaging of BxPC3 human pancreatic cancer cells is feasible with near-IR CdTeSe/CdS quantum dots (QDs) functionalized with single-domain antibody (sdAb) 2A3. For specific targeting, sdAbs are superior to conventional antibodies, especially in terms of stability, aggregation, and production cost. The bright CdTeSe/CdS QDs were synthesized to emit in the diagnostic window of 650-900 nm with a narrow emission band. 2A3 was derived from llama and is small in size of 13 kDa, but with fully-functional recognition to the target carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), a possible biomarker as a therapeutic target of pancreatic cancer. For compelling imaging, optical may be the most sensible among the various imaging modalities, regarding the sensitivity and cost. This first report on sdAb-conjugated near-IR QDs with high signal to background sensitivity for targeted cellular imaging brings insights into the development of optical molecular imaging for early stage cancer diagnosis.
Insights
Near-infrared quantum dots (QDs) conjugated with single-domain antibodies (sdAbs) enable targeted imaging of pancreatic cancer cells. This approach offers superior stability and cost-effectiveness for early cancer diagnosis.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Pancreatic cancer diagnosis remains challenging, necessitating advanced imaging techniques.
- Targeted molecular imaging offers potential for early detection and therapeutic strategies.
- Single-domain antibodies (sdAbs) present advantages over conventional antibodies for targeted delivery due to stability and cost.
Purpose of the Study:
- To develop and evaluate near-infrared (NIR) quantum dots (QDs) conjugated with a specific sdAb for targeted imaging of BxPC3 human pancreatic cancer cells.
- To assess the efficacy of sdAb-functionalized NIR QDs for sensitive and specific cellular imaging.
Main Methods:
- Synthesis of bright CdTeSe/CdS QDs emitting in the 650-900 nm diagnostic window.
- Functionalization of QDs with sdAb 2A3, targeting carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6).
- Evaluation of targeted cellular imaging using optical methods with high signal-to-background sensitivity.
Main Results:
- Successful targeted imaging of BxPC3 human pancreatic cancer cells was achieved using sdAb-conjugated NIR QDs.
- The developed QD-sdAb construct demonstrated high specificity and sensitivity for CEACAM6-expressing cells.
- Optical imaging provided compelling results with a high signal-to-background ratio.
Conclusions:
- sdAb-conjugated NIR QDs are effective for targeted imaging of pancreatic cancer cells.
- This approach shows promise for developing advanced optical molecular imaging tools for early cancer diagnosis.
- sdAbs offer a superior alternative to conventional antibodies in targeted imaging applications.
